advertisement

Topcon

Oxidative medicine and cellular longevity 21

Showing records 1 to 21 | Display all abstracts in Oxidative medicine and cellular longevity

106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Zhou L
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Shao M
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Wang J; Li M
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
He JN
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Wang S
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
He JN
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Geng Z
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Du L
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Wan Y
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Ho BM
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Liu Z
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Khattak S
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Ng DS
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Ji X
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Ma Y
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Wu D
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Chan PP
Oxidative medicine and cellular longevity 2022; 2022: 7435754
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Cao W
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106132 Role of Oxidative Stress in Retinal Disease and the Early Intervention Strategies: A Review
Dang Y
Oxidative medicine and cellular longevity 2022; 2022: 7836828
106892 Association between Serum Total Bilirubin Level and Patients with Primary Open-Angle Glaucoma in China: A Cross-Sectional, Case-Control Study
Li S
Oxidative medicine and cellular longevity 2023; 2023: 8206298
106405 Epigallocatechin-3-Gallate Protects Trabecular Meshwork Cells from Endoplasmic Reticulum Stress
Tham CC; Pang CP; Chu WK
Oxidative medicine and cellular longevity 2022; 2022: 7435754

Issue 23-3

Change Issue


advertisement

WGA Rescources